Annual Total Liabilities
$58.70 M
+$10.27 M+21.21%
31 December 2023
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares annual total liabilities is currently $58.70 million, with the most recent change of +$10.27 million (+21.21%) on 31 December 2023. During the last 3 years, it has risen by +$42.95 million (+272.65%). NAMS annual total liabilities is now at all-time high.NAMS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$60.33 M
+$1.08 M+1.82%
30 September 2024
Summary:
NewAmsterdam Pharma Company NV Ordinary Shares quarterly total liabilities is currently $60.33 million, with the most recent change of +$1.08 million (+1.82%) on 30 September 2024. NAMS quarterly total liabilities is now -21.30% below its all-time high of $76.66 million, reached on 31 March 2024.NAMS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAMS Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.2% | - |
| 3 y3 years | +272.6% | - |
| 5 y5 years | - | - |
NAMS Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +418.9% | -21.3% | +433.3% |
| 5 y | 5 years | at high | +418.9% | -21.3% | +433.3% |
| alltime | all time | at high | +418.9% | -21.3% | +433.3% |
NewAmsterdam Pharma Company NV Ordinary Shares Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $60.33 M(+1.8%) |
| June 2024 | - | $59.25 M(-22.7%) |
| Mar 2024 | - | $76.66 M(+30.6%) |
| Dec 2023 | $58.70 M | $58.70 M(+10.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $53.07 M(+9.6%) |
| Dec 2022 | $48.43 M(+328.1%) | $48.43 M(+38.7%) |
| June 2022 | - | $34.92 M(+208.7%) |
| Dec 2021 | $11.31 M(-28.2%) | $11.31 M |
| Dec 2020 | $15.75 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual total liabilities?
- What is the all time high annual total liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
- What is NewAmsterdam Pharma Company NV Ordinary Shares annual total liabilities year-on-year change?
- What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly total liabilities?
- What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
What is NewAmsterdam Pharma Company NV Ordinary Shares annual total liabilities?
The current annual total liabilities of NAMS is $58.70 M
What is the all time high annual total liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high annual total liabilities is $58.70 M
What is NewAmsterdam Pharma Company NV Ordinary Shares annual total liabilities year-on-year change?
Over the past year, NAMS annual total liabilities has changed by +$10.27 M (+21.21%)
What is NewAmsterdam Pharma Company NV Ordinary Shares quarterly total liabilities?
The current quarterly total liabilities of NAMS is $60.33 M
What is the all time high quarterly total liabilities for NewAmsterdam Pharma Company NV Ordinary Shares?
NewAmsterdam Pharma Company NV Ordinary Shares all-time high quarterly total liabilities is $76.66 M